Chunling Li Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

1/2020	Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling.
7/2018	Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunling Li Research Topics

Disease

14	Ureteral Obstruction 01/2019 - 05/2003
12	Polyuria 01/2022 - 01/2002
11	Inflammation (Inflammations) 01/2024 - 01/2016
10	Neoplasms (Cancer) 10/2023 - 09/2012
8	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 08/2004
7	Kidney Diseases (Kidney Disease) 01/2022 - 05/2015
5	Ischemia 03/2024 - 08/2004
5	Rheumatoid Arthritis 01/2021 - 09/2017
5	Nephrogenic Diabetes Insipidus 01/2019 - 10/2016
4	Wounds and Injuries (Trauma) 01/2022 - 08/2004
4	Sepsis (Septicemia) 01/2022 - 10/2008
4	Infections 01/2021 - 03/2015
3	Hypoxia (Hypoxemia) 01/2021 - 12/2018
3	Hypertension (High Blood Pressure) 09/2020 - 07/2014
3	Body Weight (Weight, Body) 12/2019 - 10/2005
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 12/2014
3	Hypercalcemia (Milk Alkali Syndrome) 03/2004 - 01/2002
2	Reperfusion Injury 03/2024 - 01/2021
2	Bites and Stings (Sting) 01/2024 - 01/2021
2	Leiomyoma (Uterine Fibroids) 06/2023 - 10/2019
2	Tuberculosis (Tuberculoses) 01/2022 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2022 - 07/2011
2	Fibrosis (Cirrhosis) 01/2022 - 10/2016
2	Obesity 01/2022 - 01/2021
2	Osteoporosis 05/2021 - 01/2019
2	Dysbiosis 09/2020 - 07/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 07/2018
2	Arthritis (Polyarthritis) 12/2019 - 09/2017
2	Experimental Arthritis 12/2019 - 09/2017
2	Acute Promyelocytic Leukemia 01/2019 - 08/2018
2	Dehydration (Water Stress) 01/2019 - 10/2016
2	Necrosis 07/2018 - 07/2010
2	Hyperglycemia 12/2014 - 06/2006
2	Acidosis 12/2009 - 08/2008
2	Endotoxemia 10/2008 - 06/2008
1	Stomach Neoplasms (Stomach Cancer) 04/2024
1	Ischemic Stroke 01/2024
1	Virus Diseases (Viral Diseases) 01/2024
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2024

Drug/Important Bio-Agent (IBA)

13	Aquaporins (Water Channels)IBA 01/2021 - 12/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2004
7	SodiumIBA 06/2008 - 11/2003
6	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 09/2017
5	Aquaporin 2IBA 01/2021 - 05/2003
5	LithiumIBA 01/2019 - 10/2016
4	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2016
4	Renin InhibitorsIBA 01/2019 - 12/2014
4	aliskiren FDA Link 01/2019 - 12/2014
4	InflammasomesIBA 01/2019 - 04/2015
3	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2016
3	Biomarkers (Surrogate Marker)IBA 09/2023 - 07/2011
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2015
3	LipidsIBA 01/2022 - 12/2014
3	CalciumIBA 01/2022 - 03/2004
3	Small Interfering RNA (siRNA)IBA 01/2020 - 07/2011
3	Vitamin D FDA LinkGeneric 01/2019 - 01/2002
3	Hormones (Hormone)IBA 09/2012 - 02/2006
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2024 - 01/2021
2	Interferon Type IIBA 01/2024 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2016
2	Circular RNAIBA 01/2023 - 11/2022
2	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2015
2	LipopolysaccharidesIBA 01/2022 - 06/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
2	CholesterolIBA 01/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Amino Acids FDA Link 01/2021 - 01/2020
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021 - 07/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2008
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 11/2018
2	FructoseIBA 09/2020 - 07/2020
2	SaltsIBA 09/2020 - 07/2020
2	Drinking WaterIBA 07/2020 - 06/2006
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2019 - 07/2010
2	Hematoxylin (Haematoxylon)IBA 12/2019 - 07/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2016
2	Tamoxifen FDA LinkGeneric 01/2019 - 09/2012
2	CreatinineIBA 01/2019 - 05/2015
2	Fibronectins (Fibronectin)IBA 07/2018 - 10/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 05/2015
2	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 02/2006
2	AcidsIBA 12/2009 - 08/2008
2	Sodium-Hydrogen ExchangersIBA 12/2009 - 06/2008
2	salicylhydroxamic acid (SHAM)IBA 12/2009 - 06/2004
2	alpha-MSHIBA 02/2006 - 08/2004
2	Urea (Carbamide)FDA LinkGeneric 10/2005 - 06/2004
2	Carrier Proteins (Binding Protein)IBA 08/2005 - 06/2004
1	Oxygen (Dioxygen)IBA 03/2024
1	O-sialoglycoprotein endopeptidaseIBA 03/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024
1	Antiviral Agents (Antivirals)IBA 01/2024
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2024
1	Pattern Recognition ReceptorsIBA 01/2024
1	InterferonsIBA 01/2024

Therapy/Procedure

13	Therapeutics 01/2024 - 09/2012
2	Transplantation 03/2024 - 02/2015
2	Immunotherapy 10/2023 - 01/2023
1	Neoadjuvant Therapy 04/2024
1	Hepatectomy 03/2024
1	Cerebral Revascularization 01/2024